
Kwang-su Yang
Examiner (ID: 9026, Phone: (571)270-7307 , Office: P/2691 )
| Most Active Art Unit | 2691 |
| Art Unit(s) | 2629, 2623, 2691, 2618 |
| Total Applications | 875 |
| Issued Applications | 616 |
| Pending Applications | 53 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11625832
[patent_doc_number] => 20170136022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/275163
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12732
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15275163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/275163 | SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR | Sep 22, 2016 | Abandoned |
Array
(
[id] => 11381583
[patent_doc_number] => 20170007639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'COLON CLEANSING OF RESIDUAL STOOL AND SECRETIONS DURING COLONOSCOPY'
[patent_app_type] => utility
[patent_app_number] => 15/273376
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10211
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/273376 | COLON CLEANSING OF RESIDUAL STOOL AND SECRETIONS DURING COLONOSCOPY | Sep 21, 2016 | Abandoned |
Array
(
[id] => 13409907
[patent_doc_number] => 20180256496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => CONTROLLED-RELEASE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 15/761053
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761053 | CONTROLLED-RELEASE FORMULATIONS | Sep 15, 2016 | Abandoned |
Array
(
[id] => 11704496
[patent_doc_number] => 20170172995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Pharmaceutical compositions of Nicotine and process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 15/265765
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265765
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/265765 | Pharmaceutical compositions of Nicotine and process for preparation thereof | Sep 13, 2016 | Abandoned |
Array
(
[id] => 14243885
[patent_doc_number] => 10272125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Transdermal delivery of cannabidiol with other active moieties including cannabinoids
[patent_app_type] => utility
[patent_app_number] => 15/265823
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 10437
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/265823 | Transdermal delivery of cannabidiol with other active moieties including cannabinoids | Sep 13, 2016 | Issued |
Array
(
[id] => 11727853
[patent_doc_number] => 20170189296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'SUNSCREEN COMPOSITIONS WITH IMPROVED WATER RESISTANCE OF UVA SUNSCREEN ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/264003
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7172
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15264003
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/264003 | Sunscreen compositions with improved water resistance of UVA sunscreen active agents | Sep 12, 2016 | Issued |
Array
(
[id] => 11497677
[patent_doc_number] => 20170071862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/260643
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36192
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260643 | Protecting oral overdose with abuse deterrent immediate release formulations | Sep 8, 2016 | Issued |
Array
(
[id] => 11491473
[patent_doc_number] => 20170065659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'COMPOSITION FOR USE IN TREATING AND/OR PREVENTING HUMAN CONDITION, DISORDER OR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/256852
[patent_app_country] => US
[patent_app_date] => 2016-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5472
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15256852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/256852 | COMPOSITION FOR USE IN TREATING AND/OR PREVENTING HUMAN CONDITION, DISORDER OR DISEASES | Sep 5, 2016 | Abandoned |
Array
(
[id] => 13761027
[patent_doc_number] => 10172842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Sustained release oral dosage form containing dalfampridine
[patent_app_type] => utility
[patent_app_number] => 15/256636
[patent_app_country] => US
[patent_app_date] => 2016-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6499
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15256636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/256636 | Sustained release oral dosage form containing dalfampridine | Sep 4, 2016 | Issued |
Array
(
[id] => 11443155
[patent_doc_number] => 20170044176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'CRYSTALLINE FORM OF TIOTROPIUM BROMIDE WITH LACTOSE'
[patent_app_type] => utility
[patent_app_number] => 15/244122
[patent_app_country] => US
[patent_app_date] => 2016-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3530
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15244122
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/244122 | Crystalline form of tiotropium bromide with lactose | Aug 22, 2016 | Issued |
Array
(
[id] => 13790701
[patent_doc_number] => 20190008889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => AGENT TO BE APPLIED TO OPHTHALMIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 15/753886
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753886 | AGENT TO BE APPLIED TO OPHTHALMIC DEVICE | Aug 18, 2016 | Abandoned |
Array
(
[id] => 12111796
[patent_doc_number] => 09867774
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-01-16
[patent_title] => 'Body lotion'
[patent_app_type] => utility
[patent_app_number] => 15/238420
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2623
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/238420 | Body lotion | Aug 15, 2016 | Issued |
Array
(
[id] => 13672417
[patent_doc_number] => 20160374942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => GELLING AGENT-BASED DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 15/238070
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238070
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/238070 | GELLING AGENT-BASED DOSAGE FORM | Aug 15, 2016 | Abandoned |
Array
(
[id] => 14372183
[patent_doc_number] => 20190160004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => IMPROVEMENTS IN CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/091688
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091688 | IMPROVEMENTS IN CANCER TREATMENT | Jul 27, 2016 | Abandoned |
Array
(
[id] => 11269157
[patent_doc_number] => 20160331704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same'
[patent_app_type] => utility
[patent_app_number] => 15/220308
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15253
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15220308
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/220308 | Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same | Jul 25, 2016 | Abandoned |
Array
(
[id] => 14243887
[patent_doc_number] => 10272126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms
[patent_app_type] => utility
[patent_app_number] => 15/216134
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 10001
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15216134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/216134 | Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms | Jul 20, 2016 | Issued |
Array
(
[id] => 11419839
[patent_doc_number] => 20170027984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/198833
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5452
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/198833 | Treatment of enteric stress from heat and infection in humans and animals by supplementation with zinc and butyric acid | Jun 29, 2016 | Issued |
Array
(
[id] => 11419681
[patent_doc_number] => 20170027825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'COSMETIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/197283
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11215
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197283
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/197283 | COSMETIC COMPOSITION | Jun 28, 2016 | Abandoned |
Array
(
[id] => 12466179
[patent_doc_number] => 09987300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
[patent_app_type] => utility
[patent_app_number] => 15/180603
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8156
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180603
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/180603 | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections | Jun 12, 2016 | Issued |
Array
(
[id] => 15420589
[patent_doc_number] => 10543196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Oral dosage forms of bendamustine
[patent_app_type] => utility
[patent_app_number] => 15/174467
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9247
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174467
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174467 | Oral dosage forms of bendamustine | Jun 5, 2016 | Issued |